The successful use of infliximab in resistant relapsing polychondritis and associated scleritis [4]

Eye

Volumn 19, Issue 2, 2005, Pages 222-224

  Cazabon, S ^a   Over, K ^a   Butcher, J ^a  

^a St Paul's Eye Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; COLLAGEN TYPE 2; CYCLOSPORIN A; INFLIXIMAB; METHOTREXATE; MYDRIATIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; CASE REPORT; CLINICAL FEATURE; CUSHINGOID SYNDROME; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG SAFETY; DRUG USE; EPISCLERITIS; FEMALE; HUMAN; HYPERTENSION; IMMUNOREACTIVITY; IMPAIRED GLUCOSE TOLERANCE; INFECTION; LETTER; MEDICAL EXAMINATION; PROTEIN FUNCTION; REACTIVE ARTHRITIS; RELAPSING POLYCHONDRITIS; SCLERITIS; SPONDYLOARTHROPATHY; TREATMENT OUTCOME; TUBERCULOSIS; UVEITIS;

EID: 14644402521     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6701457     Document Type: Letter

References (9)

1. Foidart JM, Abe S, Martin GR, Zizic TM, Barnett EU, Lawley TJ et al. Antibodies to type II collagen in relapsing polychondritis. N Engl J Med 1978; 929: 1203-1207.
2. Saxne T, Heinegard D. Involvement of nonarticular cartilage, as demonstrated by release of a cartilage specific protein, in rheumatoid arthritis. Arthritis Rheum 1989; 32: 1080-1086.
3. Michet Jr CJ, Mc Kenna CH, Luthra HS, O'Fallon WM. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med 1986; 104: 74-78.
4. Trentham DE, Le CH. Relapsing polychondritis. Ann Intern Med 1998; 129: 114-122.
5. McAdam LP, O'Hanlan MA Bluestone R, Pearson CM. Relapsing polychondritis: prospective study of 23 patients and review of the literature. Medicine 1976; 55: 193-215.
6. Van Den Bosch F, Kruithof E, Baeten D, Herssens A, de Keyser F, Mielants H et al. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondyloarthropathy. Arthritis Rheum 2002; 46 755-765.
7. Hoang-Xuan T, Foster CS, Rice BA. Scleritis in relapsing polychondritis. Response to therapy. Ophthalmology 1990; 97: 892-898.
8. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001; 345: 1098-1104.
9. Kroesen S, Widmer AF, Tyndall A, Hasler P. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF alpha therapy. Rheumatology 2003; 42: 617-621.